Data were pooled from three randomized , double-blind phase III studies of similar design that evaluated the efficacy and tolerability of tapentadol ER for the management of moderate to severe , chronic osteoarthritis knee pain ( NCT00421928 , NCT00486811 ) or low back pain ( NCT00449176 ) .